Taiko Pharmaceutical Co.,Ltd. (4574.T)
Tokyo · JPY · Healthcare · Drug Manufacturers - Specialty & Generic
¥257 (+0.00%) as of
Key statistics
- Market cap
- 12.93B
- P/E (TTM)
- 18.79
- Forward P/E
- 55.87
- EPS (TTM)
- 13.68
- Dividend yield
- 1.36%
- 52-week range
- 246.00 – 317.00
- Beta
- 0.32
- Revenue (TTM)
- 6.62B
- Profit margin
- 10.39%
- Volume
- 86.10k
About Taiko Pharmaceutical Co.,Ltd.
Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Japan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Osaka, Japan
- Employees
- 220
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.